European Archives - Page 16 of 1104 - European Medical Journal

ESCMID Global 2025: RSV-Linked Respiratory Illness Nearly Triples Adult Mortality

Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared to their peers.

ESCMID Global 2025: IL-6 Outperforms Traditional Tests for Early Sepsis Detection

A breakthrough study presented at ESCMID Global 2025 highlights IL-6 as a highly accurate early biomarker for sepsis in neonates, children, and pregnant women.

Obesity Linked to Early Biologic Resistance in Psoriasis

The study’s findings suggest that targeting the epidermal innate immune system could improve long-term treatment outcomes.

Smart ECG Shirt Monitors Heart Rate Recovery, Predicts Cardiovascular Risk

Wearable ECG shirt monitors heart rate recovery, predicting cardiovascular risk with 86% accuracy in new study.

Urodynamics Adds No Benefit in Treating Overactive Bladder

Though urodynamics altered the diagnosis in 13% of women this did not translate to improved outcomes.

How Is Industrial Pollution Impacting Global Respiratory Health?

A study analysing trends in mortality from occupational chronic respiratory diseases caused by industrial pollutants highlights both progress and ongoing challenges.

Disadvantaged Neighbourhoods and Breast Cancer Mortality Among Black Women

The study highlighted that structural factors, such as neighbourhood-level poverty and limited access to healthcare, continue to drive racial disparities in cancer outcomes.

Saliva-Based Smartphone Device Tackles Global Paediatric Tuberculosis Crisis

A smartphone-sized TB test using saliva, blood, or sputum samples boosts child diagnosis in low-resource areas.

Mental Health Impact in Patients with Lymphoma and Myeloma

A new study shows that more than 50% of patients with newly diagnosed lymphoma or myeloma suffer from anxiety and depression, significantly impacting their quality of life.

Significant Risks Associated with Long-Term ICS Use in COPD Management

Long-term ICS use in COPD is linked to increased risks of Type 2 diabetes, pneumonia, fractures, and more.